Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Krystal Biotech (KRYS) Leases (2021 - 2025)

Historic Leases for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $7.2 million.

  • Krystal Biotech's Leases rose 1527.07% to $7.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.2 million, marking a year-over-year increase of 1527.07%. This contributed to the annual value of $7.2 million for FY2025, which is 1527.07% up from last year.
  • Per Krystal Biotech's latest filing, its Leases stood at $7.2 million for Q4 2025, which was up 1527.07% from $7.4 million recorded in Q3 2025.
  • Krystal Biotech's Leases' 5-year high stood at $8.5 million during Q1 2022, with a 5-year trough of $3.2 million in Q1 2021.
  • Moreover, its 5-year median value for Leases was $7.4 million (2021), whereas its average is $7.2 million.
  • As far as peak fluctuations go, Krystal Biotech's Leases surged by 16415.62% in 2022, and later plummeted by 1262.12% in 2023.
  • Krystal Biotech's Leases (Quarter) stood at $7.2 million in 2021, then grew by 11.26% to $8.0 million in 2022, then dropped by 12.62% to $7.0 million in 2023, then dropped by 10.63% to $6.3 million in 2024, then grew by 15.27% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q4 2025, $7.4 million for Q3 2025, and $7.7 million during Q2 2025.